Search results
Mesothelioma
Health· 1 month agoThana Prasongsin / Getty Images Medically reviewed by Brian Bezack, DO Mesothelioma is an aggressive cancer of the tissues that line the mesothelium, the...
Drug said to be a breakthrough in asbestos-linked mesothelioma cancers
Scripps News via AOL· 4 months agoDr. Brad Black with the Center for Asbestos Related Disease health clinic. Researchers say they've...
‘Doctors Thought I Had Uterine Fibroids. It Was Actually A Rare Cancer.’
Women's Health via Yahoo News· 1 week agoI was a 21-year-old college student, and seeing two lines on a pregnancy test was a lot to adjust...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 9 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Merck (MRK) Buys Rights to Mid-Stage Prostate Cancer Candidate
Zacks via Yahoo Finance· 2 years agoMerck MRK announced that it is in-licensing co-development and co-commercialization rights to...
Texas Tech oncologist completes new cancer-treatment procedure
Lubbock Avalanche-Journal via Yahoo News· 1 year agoA Texas Tech oncologist recently completed a new two-step procedure to treat certain cancers, for the first time in West Texas. Dr. Tyler Mouw, a Tech Physicians surgical oncologist who offers ...
Immunotherapy for Cancer: What Are My Options?
Verywell Health via Yahoo News· 9 months agoImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immune system's ability to find and fight cancer. Since 2010,...
Guest column: State's veterans fight new foe - asbestos
Worcester Telegram & Gazette via Yahoo News· 2 weeks agoDuring the last century, asbestos use was prevalent in the U.S. military, particularly during World...
3 Top Stocks to Buy Hand Over Fist Before the End of 2022
Motley Fool· 1 year agoYou don't have to be in a hurry when it comes to buying stocks. Here are three top stocks to buy...
3 Monster Stocks in the Making to Buy Right Now
Motley Fool· 2 years agoHere's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Ginkgo Bioworks (NYSE: DNA), and Novocure (NASDAQ: NVCR). Prosper Junior Bakiny (CRISPR Therapeutics): Despite tremendous medical progress ...